We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Detoxification Procedure for Heroin Addicts

By HospiMedica staff writers
Posted on 23 Oct 2001
A critical-care procedure for addicted heroin users, called ultrarapid opiate detoxification (UROD), is designed to help users avoid painful withdrawal and recover from their addiction. More...
The procedure should only be performed under the supervision of an anesthesiologist, according to research presented at the annual meeting of the American Society of Anesthesiologists (ASA) in New Orleans (LA, USA).

The UROD procedure, in which the patient is first put to sleep and then allowed to gain consciousness, takes four to six hours, plus 24 hours of hospitalization. Because the procedure causes drastic physical changes in the patient, it should be closely monitored by an anesthesiologist. This is followed by several months of daily medications called antagonists to block the effects of narcotics and reduce the compulsion to again abuse drugs. According to one study, 55% of patients had not resumed drug use six months after the procedure. For some patients, the procedure offers a viable alternative to methadone maintenance.

An analysis of the deaths of seven patients who underwent the procedure was presented at the meeting by Dr. Clifford M. Gevirtz, an anesthesiologist at Mount Sinai School of Medicine (New York, NY, USA). All seven procedures were performed by nurse anesthetists under the supervision of an internist, not an anesthesiologist. Six deaths were caused by pulmonary edema, while the seventh was caused by pneumonia due to aspiration of material from the stomach into the lungs. The analysis also revealed deviations from standard practice, including the absence of a pre-anesthetic evaluation for all seven patients, the administration of anesthetic drugs without regard for body weight or level of muscle relaxation, a lack of appropriate monitoring, and failure to administer medicines to prevent aspiration.

"UROD requires the precise control of anesthesia during the administration of antagonists and strict adherence to the ASA standards of care,” said Dr. Gevirtz. "We believe the seven deaths could have been prevented had proper precautions and techniques been employed by an anesthesiologist.”




Related Links:
Mount Sinai

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.